Skip to Main Content
An official website of the United States government

Approved Projects

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Filter results of approved projects table below

Approved Projects
Name Principal Investigator Institution Study Date Approved Project ID
Exploring the latent space of integrated heterogeneous data sources in breast cancer David Longo Emergent Dynamics PLCO May 12, 2020 PLCO-623
Exploring the Relationship Between Lifestyle Factors and Early-Stage Lung Cancer Using Publicly Available U.S. Data Stephen (Jihao) Tao Minot State University NLST Sep 16, 2024 NLST-1321
Exploring the Viability of New Technology to Quickly Determine All Feature Contributions, Feature Value Contributions, Feature Interactions, and Feature Value Interactions that lead to cancer. Victor McGuire Renown AI, Inc. PLCO Jul 19, 2023 PLCO-1275
Expression levels and prostate cancer recurrence in PLCO Michael Cook NCI PLCO Oct 22, 2012 2012-0312
Extended Cancer Prediction from Lung CT Images Atilla Kiraly Google NLST Nov 1, 2019 NLST-594
Extended follow-up NLST data to support provision of biosample data to requesters Ilana Gareen Brown University NLST May 30, 2023 NLST-1062
External Data Integration in Prostate Cancer Trials Md Tuhin Sheikh Arizona State University PLCO Oct 7, 2024 PLCO-1694
External validation of a chest radiograph-based prognostic model Hyungjin Kim Seoul National University Hospital PLCO Apr 28, 2023 PLCOI-1208
External validation of a chest radiograph-based prognostic model Jongmin Kim MEDICAL IP PLCO Jun 2, 2023 PLCOI-1242
External validation of a chest radiograph-based quantification model for the cardiovascular system Hyungjin Kim Seoul National University Hospital PLCO May 2, 2023 PLCOI-1216
External validation of a risk stratification tool for ovarian cancer using PLCO data Celeste Leigh Pierce University of Wisconsin-Madison PLCO Nov 15, 2023 PLCO-1393
Extracting Image Features with Deep Learning to Improve Cancer Risk Calculation Hormuzd Katki NCI NLST Jul 11, 2019 NLST-537
Extrapulmonary malignancy as a cause of mortality in the NLST Myrna Godoy MD Anderson Cancer Center - The University of Texas NLST Mar 30, 2016 NLST-200
Eye-tracking to find missed Lung Nodules Gregory DiGirolamo University of Massachusetts, Chan Medical School NLST Sep 6, 2022 NLST-953
Facilitating Cancer Etiology and Early Marker Research by Enabling Access to PLCO Data and Biospecimens Danielle Carrick Westat PLCO Mar 20, 2008 2008-0007
Factors affecting post lead time survival in NLST participants Grant Izmirlian National Cancer Institute NLST May 7, 2014 NLST-72
Factors Associated with Inappropriate Use of Head Imaging in the Staging of Early Stage Non Small Cell Lung Cancer Alex Balekian USC Keck School of Medicine NLST Jan 27, 2014 NLST-49
Factors associated with small aggressive NSCLC abnormal suspicious CXR screens. Martin Tammemagi Henry Ford Health System NLST Oct 25, 2011 201110-0017
Factors Associated with the Timing of Follow-up After an Abnormal Cancer Screening Beth Waitzfelder Pacific Health Research Institute (Hawaii) PLCO Apr 30, 2009 2009-0023
Factors associated with time to diagnosis in abnormal suspicious screens in the NLST. Martin Tammemagi Henry Ford Health System NLST Feb 24, 2012 201202-0028